Correspondence 0001104659-23-122728 from STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194) (LAB)
STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194)
Date: Dec. 1, 2023 · CIK: 0001162194 · Accession: 0001104659-23-122728
AI Filing Summary & Sentiment
File numbers found in text: 333-275533
Letter
Standard BioTools Inc.
2 Tower Place, Suite 2000
South San Francisco, CA
December 1, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Ansart
RE: Standard BioTools Inc.
Registration Statement on Form S-4, as amended, File No. 333-275533
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Standard BioTools Inc. (the “Company”) hereby requests acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-275533) (as amended, the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern Time on Friday, December 1, 2023 or as soon as possible thereafter.
The Company hereby authorizes Matthew J. Gardella, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.
The Company respectfully requests that it be notified of such effectiveness by a telephone call to Mr. Gardella at (617) 348-1735 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Mr. Gardella.
Very truly yours,
Standard
biotools INC.
Show Raw Text
CORRESP
1
filename1.htm
Standard BioTools Inc.
2 Tower Place, Suite 2000
South San Francisco, CA
December 1, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Ansart
RE: Standard BioTools Inc.
Registration Statement on Form S-4, as amended,
File No. 333-275533
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461
promulgated under the Securities Act of 1933, as amended, Standard BioTools Inc. (the “Company”) hereby requests
acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-275533) (as amended, the “Registration
Statement”), so that it may become effective at 4:00 p.m. Eastern Time on Friday, December 1, 2023 or as soon as possible thereafter.
The Company hereby authorizes
Matthew J. Gardella, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.
The Company respectfully requests
that it be notified of such effectiveness by a telephone call to Mr. Gardella at (617) 348-1735 and that such effectiveness also
be confirmed in writing. Any questions regarding this request may be addressed to Mr. Gardella.
Very truly yours,
Standard
biotools INC.
/s/
Jeffrey Black
Jeffrey Black
Chief Financial Officer
cc: Standard BioTools Inc.
Michael Egholm, Ph.D., President and Chief Executive
Officer
Agnieszka Gallagher, Esq., Senior Vice President
and Chief Legal Officer
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo,
P.C.
Matthew J. Gardella, Esq.